(Q70165310)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3028662%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

title

Experience with ifosfamide combinations (etoposide or DDP) in non-small cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3028662%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference

1 reference

P Drings

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3028662%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

U Abel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3028662%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

H Bülzebruck

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3028662%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

P Stiefel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3028662%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

M Kleckow

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3028662%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

H G Manke

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3028662%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

publication date

1 January 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3028662%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

9 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3028662%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

volume

18 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3028662%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

page(s)

S34-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3028662%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00647449

9 October 2019

exact match

0 references

cites work

Combination chemotherapy of bronchogenic carcinoma. I. Non-oat cell

1 reference

12 December 2020

VP-16-213 chemotherapy for advanced squamous cell carcinoma and adenocarcinoma of the lung

1 reference

12 December 2020

cis-Dichlorodiammineplatinum(II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide in combination for adenocarcinoma of the lung

1 reference

12 December 2020

Role of chemotherapy in the treatment of lung cancer: evolving strategies for non-small cell histologies

1 reference

12 December 2020

Cis-diamminedichloroplatinum(II): a new type of cytostatic

1 reference

12 December 2020

High-dose cisplatin for lung cancer

1 reference

12 December 2020

Progress in chemotherapy of non-small cell lung cancer

1 reference

12 December 2020

Etoposide--an effective single drug for treating bronchogenic carcinoma

1 reference

12 December 2020

Ifosfamide in the treatment of extensive non-oat cell carcinoma of the lung

1 reference

12 December 2020

Efficacy study of intensive cis-platin therapy in advanced non-small cell bronchogenic carcinoma

1 reference

12 December 2020

Commentary: current status of chemotherapy for non-small cell lung cancer

1 reference

12 December 2020

Platinum-based polychemotherapy versus dianhydrogalactitol in advanced non-small cell lung cancer

1 reference

12 December 2020

High-dose cisplatin with fluid and mannitol-induced diuresis in advanced lung cancer: a phase II clinical trial of the EORTC Lung Cancer Working Party (Belgium).

1 reference

12 December 2020

Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules

1 reference

12 December 2020

Chemotherapy of the non-small cell carcinoma of the lung with ifosfamide and cisplatin

1 reference

12 December 2020

Chemotherapy for adenocarcinoma and large cell anaplastic carcinoma of the lung with ftorafur, adriamycin, and cis-dichlorodiammineplatinum(II)

1 reference

12 December 2020

cis-Dichlorodiammineplatinum(II), adriamycin, cyclophosphamide, CCNU, and vincristine in non-small cell lung carcinoma: a preliminary report

1 reference

12 December 2020

Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum (II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lung

1 reference

12 December 2020

Cis-diamminedichloroplatinum (II). A new anticancer drug

1 reference

12 December 2020

Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future

1 reference

12 December 2020

Phase II trial of VP16-213 in non-small cell lung cancer (NSCLC)

1 reference

12 December 2020

The renal pathology in clinical trials of cis-platinum (II) diamminedichloride

1 reference

12 December 2020

Phase II study of high-dose cis-dichlorodiammineplatinum(II) in the treatment of non-small cell lung cancer

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00647449

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3028662%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference